919 related articles for article (PubMed ID: 33614199)
21. Opsoclonus-myoclonus-ataxia syndrome associated with chikungunya and dengue virus co-infection.
do Rosário MS; Giovanetti M; de Jesus PAP; Farias DS; Faria NR; de Lima CPS; da Silva SP; Nunes MR; Alcantara LCJ; de Siqueira IC
Int J Infect Dis; 2018 Oct; 75():11-14. PubMed ID: 30076990
[TBL] [Abstract][Full Text] [Related]
22. Topiramate response in adult-onset opsoclonus-myoclonus-ataxia syndrome: A case report.
Degirmenci Y; Kececi H
Rev Neurol (Paris); 2017 Jun; 173(6):418-420. PubMed ID: 28461028
[No Abstract] [Full Text] [Related]
23. Probable association between mRNA COVID-19 vaccine and opsoclonus-myoclonus-ataxia syndrome.
Deniz A; Alikılıç D; Öztürk M; Karaca Ö; Güngör M; Kara B
J AAPOS; 2023 Apr; 27(2):110-112. PubMed ID: 36736453
[TBL] [Abstract][Full Text] [Related]
24. Opsoclonus myoclonus syndrome in a patient with Japanese encephalitis: a case report.
Sountharalingam S; Herath HMMTB; Wijegunasinghe D; Senanayke S
J Med Case Rep; 2017 Oct; 11(1):294. PubMed ID: 29058581
[TBL] [Abstract][Full Text] [Related]
25. Update on opsoclonus-myoclonus syndrome in adults.
Oh SY; Kim JS; Dieterich M
J Neurol; 2019 Jun; 266(6):1541-1548. PubMed ID: 30483882
[TBL] [Abstract][Full Text] [Related]
26. Innovative and effective immunosuppressive bitherapy for an unusual paraneoplastic opsoclonus-myoclonus-ataxia syndrome of the adult.
León Ruiz M; Benito-León J; García-Soldevilla MA; Rubio-Pérez L; Parra Santiago A; Lozano García-Caro LA; Izquierdo Esteban L; Hernández Martínez AC; González Estecha A; García-Albea Ristol E
Neurologia; 2017 Mar; 32(2):122-125. PubMed ID: 26059806
[No Abstract] [Full Text] [Related]
27. Opsoclonus-myoclonus syndrome associated with herpes simplex virus infection: a case report.
Chen Y; Chen D; Zhou X; Zhang H; Liao S; Xu Z; Xu P
Int J Neurosci; 2021 Mar; 131(3):307-311. PubMed ID: 32116082
[No Abstract] [Full Text] [Related]
28. HIV-associated opsoclonus-myoclonus-ataxia syndrome: early infection, immune reconstitution syndrome or secondary to other diseases? Case report and literature review.
Guedes BF; Vieira Filho MAA; Listik C; Carra RB; Pereira CB; Silva ERD; Gomes HR; Vidal JE
J Neurovirol; 2018 Feb; 24(1):123-127. PubMed ID: 29243132
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and prognostic analysis of opsoclonus-myoclonus-ataxia syndrome in children].
Zhou J; Zhuo XW; Jin M; Duan C; Zhang WH; Ren CH; Gong S; Tian XJ; Ding CH; Ren XT; Li JW
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):256-261. PubMed ID: 38378288
[No Abstract] [Full Text] [Related]
30. Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 Infection.
Shah PB; Desai SD
Neurology; 2021 Jan; 96(1):33. PubMed ID: 33004603
[No Abstract] [Full Text] [Related]
31. Clonazepam responsive opsoclonus myoclonus syndrome: additional evidence in favour of fastigial nucleus disinhibition hypothesis?
Paliwal VK; Chandra S; Verma R; Kalita J; Misra UK
J Neural Transm (Vienna); 2010 May; 117(5):613-5. PubMed ID: 20094737
[TBL] [Abstract][Full Text] [Related]
32. Successful use of tacrolimus for treatment-refractory neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: A case series.
Delap S; Shah N; Kuns O; Franklin B; Skeens MA
Pediatr Blood Cancer; 2024 Apr; 71(4):e30903. PubMed ID: 38321586
[TBL] [Abstract][Full Text] [Related]
33. [Opsoclonus-myoclonus syndrome].
Arroyo HA; Tringler N
Medicina (B Aires); 2009; 69(1 Pt 1):64-70. PubMed ID: 19240003
[TBL] [Abstract][Full Text] [Related]
34. [Opsoclonus-myoclonus-ataxia syndrome: two anatomo-clinical case reports].
Gabaldon-Torres L; Fernandez-Dominguez J; Salas-Felipe J; Caminoa-Lizarralde A; Palomo-Ferrer F; Gutierrez-Molina M; Morales-Bastos C; de Sarria-Lucas MJ; Arpa-Gutierrez FJ
Rev Neurol; 2009 Feb 1-15; 48(3):137-40. PubMed ID: 19206061
[TBL] [Abstract][Full Text] [Related]
35. [Ataxia, Involuntary Movement and Paroxysmal Motor Abnormality Associated with COVID-19 Infection].
Takahashi M
Brain Nerve; 2022 Jul; 74(7):861-866. PubMed ID: 35860932
[TBL] [Abstract][Full Text] [Related]
36. Late cognitive and adaptive outcomes of patients with neuroblastoma-associated opsoclonus-myoclonus-ataxia-syndrome: A report from the Children's Oncology Group.
Kumar P; Willard VW; Embry L; Naranjo A; LaBarre B; Matthay KK; de Alarcon PA
Pediatr Blood Cancer; 2024 Jul; 71(7):e31039. PubMed ID: 38689540
[TBL] [Abstract][Full Text] [Related]
37. Clinical features and outcomes of opsoclonus myoclonus ataxia syndrome.
Yıldırım M; Öncel İ; Bektaş Ö; Tanalı G; Şahin S; Kutluk T; Teber S; Anlar B
Eur J Paediatr Neurol; 2022 Nov; 41():19-26. PubMed ID: 36155293
[TBL] [Abstract][Full Text] [Related]
38. New-Onset Movement Disorders Associated with COVID-19.
Brandão PRP; Grippe TC; Pereira DA; Munhoz RP; Cardoso F
Tremor Other Hyperkinet Mov (N Y); 2021; 11():26. PubMed ID: 34277139
[TBL] [Abstract][Full Text] [Related]
39. Opsoclonus myoclonus ataxia associated with West Nile virus infection: A dramatic presentation with benign prognosis?
Zaltzman R; Klein C; Gordon CR
J Neurol Sci; 2017 May; 376():38-41. PubMed ID: 28431624
[TBL] [Abstract][Full Text] [Related]
40. Pediatric opsoclonus-myoclonus-ataxia syndrome: Experience from a tertiary care university hospital.
Huddar A; Bindu PS; Nagappa M; Bharath RD; Sinha S; Mathuranath PS; Taly AB
Neurol India; 2018; 66(5):1332-1337. PubMed ID: 30232999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
